(Q39939298)

15 September 2017

Public health impact of antiviral therapy for hepatitis C in the United States (English)

1 reference

15 September 2017

0 references

United States of America

0 references

1 reference

Michael L Volk

1

1 reference

15 September 2017

Rachel Tocco

series ordinal

2

1 reference

15 September 2017

Sameer Saini

series ordinal

3

1 reference

15 September 2017

Anna S F Lok

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

15 September 2017

1 reference

15 September 2017

50

1 reference

15 September 2017

6

1 reference

15 September 2017

1750-1755

1 reference

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

15 September 2017

1 reference

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment

21 January 2018

1 reference

Projecting future complications of chronic hepatitis C in the United States

21 January 2018

1 reference

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials

21 January 2018

1 reference

Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.

21 January 2018

1 reference

Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death

21 January 2018

1 reference

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

21 January 2018

1 reference

High rates of uninsured among HCV-positive individuals

21 January 2018

1 reference

Regular sources of medical care among persons with severe mental illness at risk of hepatitis C infection.

21 January 2018

1 reference

Management of hepatitis C patients by primary care physicians in the USA: results of a national survey

21 January 2018

1 reference

A balancing view: We cannot do it alone

21 January 2018

1 reference

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

21 January 2018

1 reference

Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors

21 January 2018

1 reference

Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Market uptake of new antiviral drugs for the treatment of hepatitis C.

21 January 2018

1 reference

A step forward in therapy for hepatitis C.

21 January 2018

1 reference

Primary care: is there enough time for prevention?

21 January 2018

1 reference

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

21 January 2018

1 reference

Liver and intestine transplantation in the United States, 1997-2006

21 January 2018

1 reference

7 January 2021

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study

1 reference

7 January 2021

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

7 January 2021

Interferon therapy prolonged life expectancy among chronic hepatitis C patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23220

1 reference

15 September 2017

1 reference